- Lobbying
- Lobbying by Dendreon Pharmaceuticals LLC
Lobbying Relationship
Bills mentioned
S.2543: Prescription Drug Pricing Reduction Act of 2019
Sponsor: Charles E. Grassley (R-Iowa)
H.R.3: Elijah E. Cummings Lower Drug Costs Now Act
Sponsor: Frank Pallone (D-N.J.)
H.R.19: Lower Costs, More Cures Act of 2019
Sponsor: Greg Walden (R-Ore.)
S.3129: Lower Costs, More Cures Act of 2019
Sponsor: Michael D. Crapo (R-Idaho)
H.R.748: CARES Act
Sponsor: Joe Courtney (D-Conn.)
S.748: Medicare Sequester Relief Act
Sponsor: Jeanne Shaheen (D-N.H.)
H.R.1868: To prevent across-the-board direct spending cuts, and for other purposes.
Sponsor: John Yarmuth (D-Ky.)
H.R.315: Medicare Sequester COVID Moratorium Act
Sponsor: Brad Schneider (D-Ill.)
H.R.1999: Protect Seniors and Cut Waste Act
Sponsor: Jason Smith (R-Mo.)
H.R.5376: Inflation Reduction Act of 2022
Sponsor: John Yarmuth (D-Ky.)
H.R.1176: PSA Screening for HIM Act
Sponsor: Bobby L. Rush (D-Ill.)
H.R.1826: Prostate-Specific Antigen Screening for High-risk Insured Men Act
Sponsor: Larry Bucshon (R-Ind.)
H.R.2673: American Innovation and R&D Competitiveness Act of 2023
Sponsor: Ron Estes (R-Kansas)
S.2821: PSA Screening for HIM Act
Sponsor: Cory Booker (D-N.J.)
S.866: American Innovation and Jobs Act
Sponsor: Margaret Hassan (D-N.H.)
H.R.7024: Tax Relief for American Families and Workers Act of 2024
Sponsor: Jason Smith (R-Mo.)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
John McManus | Staff Director, W&M Health Subcommittee; LA, Rep. Bill Thomas. LA, Bill Thomas. Staff Director, W&M Health Subcommittee |
Barrett Thornhill | LA, Sen. Crapo & Rep. Toomey; LA and Press Sec., Rep. Norwood. LA, Sen. Crapo and Rep. Toomey. LA and Press Secretary, Rep. Norwood. |
ALANNA TEMME | LD, Rep. Jon Porter |
Paul Cronan | n/a |
Christina Hochul | n/a |
Alex Whalen Mr. | n/a |
Alex Whalen | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
Health & Human Services - Dept of (HHS)
U.S. House of Representatives
Health & Human Services - Dept of (HHS)
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate